Automatic Implantable Cardioverter Defibrillator

Manolis, Antonis S.; Rastegar, Hassan; Estes III, A. Mark
September 1989
JAMA: Journal of the American Medical Association;9/8/89, Vol. 262 Issue 10, p1362
Academic Journal
Discusses the development of the automatic implantable cardioverter defibrillator (ACID). Design of the apparatus to detect and terminate ventricular tachycardia (VT) or fibrillation (VF); Evolution from an investigation to a clinical tool for management of malignant ventricular arrhythmias; Components of the ACID system; System and unit operations; Suitability of AICD for cardiac arrest patients.


Related Articles

  • PREDICTION AND PREVENTION OF SUDDEN CARDIAC DEATH IN HEART FAILURE. Lane, Rebecca E.; Cowie, Martin R.; Chow, Anthony W. C. // Heart;May2005, Vol. 91 Issue 5, p674 

    The article focuses on the prediction and prevention of sudden cardiac death (SCD) in heart failure. The degeneration of monomorphic ventricular tachycardia into ventricular fibrillation accounts for the majority of sudden arrhythmic deaths. The implantable cardioverter-defibrillator (lCD) is...

  • Impending Sudden Cardiac Death: Treatment With Myocardial Revascularization and the Automatic Implantable Cardioverter Defibrillator.  // JAMA: Journal of the American Medical Association;6/16/89, Vol. 261 Issue 23, p3394 

    Discusses the abstract of the article 'Impending Sudden Cardiac Death: Treatment With Myocardial Revascularization and the Automatic Implantable Cardioverter Defibrillator,' by James D. Fonger et al., published in a 1988 issue of the 'Annals of Thoracic Surgery' journal.

  • Sudden Cardiac Death and Implantable Cardioverter Defibrillations (lCD) and the Older Adult. Hyder, Omar; Ziv, Obad // Medicine & Health Rhode Island;Jan2010, Vol. 93 Issue 1, p27 

    The article discusses the importance of implantable cardioverter defibrillators (ICDs) in improving survival rates of sudden cardiac arrest (SCA) which results from a hemodynamically unstable heart rhythm such as ventricular fibrillation or ventricular tachycardia. It mentions that failure of...

  • Driving and ICD Shocks for Ventricular Arrhythmias. DiMarco, John P. // Clinical Cardiology Alert;Jan2008, Vol. 27 Issue 1, p6 

    The triggers of ventricular arrhythmia (tova Study) was a multicenter, prospective, cohort study that examined lifestyle and psychological triggers that might result in implantable cardioverterdefibrillator (ICD) shocks for ventricular tachycardia (VT) or ventricular fibrillation (VF). The study...

  • Arrhythmias and Left Ventricular Hypertrabeculation/Noncompaction. Stöllberger, C.; Finsterer, J. // Current Pharmaceutical Design;9/1/2010, Vol. 16 Issue 26, p2880 

    No abstract available.

  • QUIETING ELECTRICAL STORMS OF THE HEART.  // Prevention;Sep89, Vol. 41 Issue 9, p62 

    Discusses advances in the treatment of ventricular arrhythmia, a type of electrical malfunction in the heart. Difference between ventricular tachycardia and ventricular fibrillation; Factors that contribute to the development of ventricular arrhythmias; Development of the automatic implantable...

  • Implantable Cardioverter-Defibrillators at the End of Life. Klotter, Jule // Townsend Letter;May2012, Issue 346, p23 

    The article reports on the benefits and effects of implantable cardioverter-defibrillators (ICDs) that are used to restore normal heart rhythm in people suffering from ventricular tachycardia and ventricular fibrillation. It cites a taxonomic review which reveals that ICDs are seldom included in...

  • Cost effectiveness of implantable cardioverter defibrillator therapy versus drug therapy for patients at high risk of sudden cardiac death. Spath, M.A.; O'Brien, B.J.; Spath, Marian A; O'Brien, Bernie J // PharmacoEconomics;2002, Vol. 20 Issue 11, p727 

    The implantable cardioverter defibrillator (ICD) is a therapy for patients at risk of sudden cardiac death due to ventricular tachycardia (VT) or ventricular fibrillation (VF). But the apparent high cost of ICD therapy relative to antiarrhythmic drugs such as amiodarone has raised questions...

  • Fish oil may be proarrythmic in patients with VT or VF.  // Reactions Weekly;6/25/2005, Issue 1057, p3 

    Discusses research being done on fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators. Reference to a study by M. H. Raitt et al published in the June 15, 2005 issue of the "Journal of the American Medical...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics